| Gene symbol | CD19 | Synonyms | B4, CVID3 | Type of gene | protein-coding |
| Chromosome | 16 | Map location | 16p11.2 | dbXrefs | |
| Description | CD19 molecule | ||||
| GTO ID | GTC3802 |
| Trial ID | NCT06310811 |
| Disease | Systemic Lupus Erythematosus |
| Altered gene | CD19 |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | RD06-04 |
| Recruitment status | Recruiting |
| Title | A Safety, Efficacy, and Pharmacokinetics Study of Anti-CD19 CAR-T Cell Therapy in Participants With Moderate to Severe Active Systemic Lupus Erythematosus |
| Year | 2024 |
| Country | China |
| Company sponsor | Wuhan Union Hospital, China |
| Other ID(s) | BHCT-RD06-04-01 |
| Cohort 1 | |||||||||
|
|||||||||